These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 14710361

  • 21. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
    Poincloux R, Lizárraga F, Chavrier P.
    J Cell Sci; 2009 Sep 01; 122(Pt 17):3015-24. PubMed ID: 19692588
    [Abstract] [Full Text] [Related]

  • 22. [Matrix metalloproteinases and colorectal cancer].
    Roeb E, Matern S.
    Med Klin (Munich); 2003 Dec 15; 98(12):763-70. PubMed ID: 14685678
    [Abstract] [Full Text] [Related]

  • 23. Matrix metalloproteinases in wound repair (review).
    Ravanti L, Kähäri VM.
    Int J Mol Med; 2000 Oct 15; 6(4):391-407. PubMed ID: 10998429
    [Abstract] [Full Text] [Related]

  • 24. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
    Park HJ, Chung HJ, Min HY, Park EJ, Hong JY, Kim WB, Kim SH, Lee SK.
    Biochem Pharmacol; 2005 Dec 19; 71(1-2):21-31. PubMed ID: 16271263
    [Abstract] [Full Text] [Related]

  • 25. [Structure and function of matrix metalloproteinases].
    Olszyński K, Zimowska M.
    Postepy Biochem; 2009 Dec 19; 55(1):76-84. PubMed ID: 19514468
    [Abstract] [Full Text] [Related]

  • 26. Matrix metalloproteinases target protease-activated receptors on the tumor cell surface.
    Pei D.
    Cancer Cell; 2005 Mar 19; 7(3):207-8. PubMed ID: 15766657
    [Abstract] [Full Text] [Related]

  • 27. Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion.
    Philip S, Bulbule A, Kundu GC.
    Glycoconj J; 2004 Mar 19; 21(8-9):429-41. PubMed ID: 15750784
    [Abstract] [Full Text] [Related]

  • 28. Matrix metalloproteinases and bladder cancer.
    Kanayama H.
    J Med Invest; 2001 Feb 19; 48(1-2):31-43. PubMed ID: 11286015
    [Abstract] [Full Text] [Related]

  • 29. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB, Houben R, Bröcker EB, Becker JC.
    Biochimie; 2005 Feb 19; 87(3-4):307-14. PubMed ID: 15781317
    [Abstract] [Full Text] [Related]

  • 30. The other side of MMPs: protective roles in tumor progression.
    Martin MD, Matrisian LM.
    Cancer Metastasis Rev; 2007 Dec 19; 26(3-4):717-24. PubMed ID: 17717634
    [Abstract] [Full Text] [Related]

  • 31. MT1-MMP: a potent modifier of pericellular microenvironment.
    Itoh Y, Seiki M.
    J Cell Physiol; 2006 Jan 19; 206(1):1-8. PubMed ID: 15920734
    [Abstract] [Full Text] [Related]

  • 32. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
    Masson V.
    Bull Mem Acad R Med Belg; 2006 Jan 19; 161(5):320-6. PubMed ID: 17283905
    [Abstract] [Full Text] [Related]

  • 33. Complex roles of tissue inhibitors of metalloproteinases in cancer.
    Jiang Y, Goldberg ID, Shi YE.
    Oncogene; 2002 Mar 28; 21(14):2245-52. PubMed ID: 11948407
    [Abstract] [Full Text] [Related]

  • 34. Membrane associated matrix metalloproteinases in metastasis.
    Ellerbroek SM, Stack MS.
    Bioessays; 1999 Nov 28; 21(11):940-9. PubMed ID: 10517867
    [Abstract] [Full Text] [Related]

  • 35. MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-alpha levels.
    Hiden U, Glitzner E, Ivanisevic M, Djelmis J, Wadsack C, Lang U, Desoye G.
    Diabetes; 2008 Jan 28; 57(1):150-7. PubMed ID: 17928399
    [Abstract] [Full Text] [Related]

  • 36. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
    Mannello F.
    Clin Chim Acta; 2009 Nov 28; 409(1-2):1-3. PubMed ID: 19632213
    [Abstract] [Full Text] [Related]

  • 37. Metalloproteinases in tumor progression: the contribution of MMP-9.
    Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW, Muschel RJ.
    Invasion Metastasis; 2009 Nov 28; 14(1-6):246-58. PubMed ID: 7657517
    [Abstract] [Full Text] [Related]

  • 38. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
    Tang Y, Kesavan P, Nakada MT, Yan L.
    Mol Cancer Res; 2004 Feb 28; 2(2):73-80. PubMed ID: 14985463
    [Abstract] [Full Text] [Related]

  • 39. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y.
    J Pathol; 2004 Apr 28; 202(4):403-11. PubMed ID: 15095267
    [Abstract] [Full Text] [Related]

  • 40. A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.
    Ishii Y, Nakasato Y, Kobayashi S, Yamazaki Y, Aoki T.
    J Exp Clin Cancer Res; 2003 Sep 28; 22(3):461-70. PubMed ID: 14582707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.